Arcutis Biotherapeutics

Arcutis champions innovation that addresses unmet patient needs—solving the everyday medical dermatology challenges that significantly impact patients and their families. With a passion for understanding what really matters to patients and healthcare providers, Arcutis leverages extensive dermatology development expertise to meaningfully advance the treatment of immune-mediated skin diseases. Arcutis’ robust pipeline includes multiple development programs for a range of inflammatory dermatological conditions, with several significant clinical data readouts anticipated through 2023. Arcutis has the potential to advance the standard of care for plaque psoriasis, atopic dermatitis, seborrheic dermatitis, and scalp psoriasis. Visit www.arcutis.com or follow Arcutis on LinkedIn and Twitter.